Table 5

Donor vs no-donor analysis using a 3-mo RFS landmark

HR* (95% CI)P
CIR 0.46 (0.30-0.72) .001 
NRM 2.05 (1.03-4.11) .042 
RFS 0.75 (0.53-1.07) .11 
OS 0.75 (0.51-1.09) .13 
HR* (95% CI)P
CIR 0.46 (0.30-0.72) .001 
NRM 2.05 (1.03-4.11) .042 
RFS 0.75 (0.53-1.07) .11 
OS 0.75 (0.51-1.09) .13 

This analysis was performed in the 235 patients in continuous CR 3 mo after CR achievement (n = 160 with a donor; n = 75 without a donor).

*

HR in donor vs no-donor group.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal